Cara Therapeutics, Inc. (CARA) Announces Difelikefalin (KORSUVA™) Injection Achieves Positive Topline Results in Phase 3 Clinical Study

Cara Therapeutics Announces Difelikefalin (KORSUVA™) Injection Achieves Positive Topline Results in Phase…

Tilray, Inc. (TLRY) Reports Profitable Second Quarter Fiscal Year 2022 Financial Results

Tilray, Inc. Reports Profitable Second Quarter Fiscal Year 2022 Financial Results Tilray,…